Related references
Note: Only part of the references are listed.Caveat fluorophore: an insiders' guide to small-molecule fluorescent labels
Jonathan B. Grimm et al.
NATURE METHODS (2022)
INDI-integrated nanobody database for immunoinformatics
Piotr Deszynski et al.
NUCLEIC ACIDS RESEARCH (2022)
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
Toon Laeremans et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells
Dehan Comez et al.
FRONTIERS IN IMMUNOLOGY (2022)
New small molecule fluorescent probes for G protein-coupled receptors: valuable tools for drug discovery
Joshua W. Conner et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization
Aurelien Zarca et al.
CELLS (2021)
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
Phillip Pymm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization
Astrid S. Jorgensen et al.
COMMUNICATIONS BIOLOGY (2021)
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies
Timo W. M. De Groof et al.
NATURE COMMUNICATIONS (2021)
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19
Jiandong Huo et al.
NATURE COMMUNICATIONS (2021)
D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling
Shanshan Song et al.
EBIOMEDICINE (2021)
Improved HaloTag Ligand Enables BRET Imaging With NanoLuc
Ovia Margaret Thirukkumaran et al.
FRONTIERS IN CHEMISTRY (2020)
Development of a Novel SPR Assay to Study CXCR4-Ligand Interactions
Arnaud Boonen et al.
BIOSENSORS-BASEL (2020)
Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies
Mark Soave et al.
CELL CHEMICAL BIOLOGY (2020)
CRISPR-Mediated Protein Tagging with Nanoluciferase to Investigate Native Chemokine Receptor Function and Conformational Changes
Carl W. White et al.
CELL CHEMICAL BIOLOGY (2020)
Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs
Timo W. M. De Groof et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Nanobodies detecting and modulating GPCRs outside in and inside out
Raimond Heukers et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
Barbara D. Jakobs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Drug-Target Association Kinetics in Drug Discovery
Adriaan P. IJzerman et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells
Timo W. M. De Groof et al.
MOLECULAR PHARMACEUTICS (2019)
NanoBRET: The Bright Future of Proximity-Based Assays
Natasha C. Dale et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth
Raimond Heukers et al.
ONCOGENE (2018)
Intracellular Receptor Modulation: Novel Approach to Target GPCRs
Natalia V. Ortiz Zacarias et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry
Anneleen Van Hout et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions
Vladimir Bobkov et al.
BIOCHEMICAL PHARMACOLOGY (2018)
GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications
Eric A. Wold et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
sdAb-DB: The Single Domain Antibody Database
Emily E. Wilton et al.
ACS SYNTHETIC BIOLOGY (2018)
Drug-Target Kinetics in Drug Discovery
Peter J. Tonge
ACS CHEMICAL NEUROSCIENCE (2018)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Nanobody Technology: A versatile Toolkit for Microscopic imaging, Protein-Protein interaction Analysis, and Protein Function exploration
Els Beghein et al.
FRONTIERS IN IMMUNOLOGY (2017)
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
Jing Zuo et al.
BMC GENOMICS (2017)
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics
Daniel M. Freed et al.
CELL (2017)
Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
Doris A. Schuetz et al.
DRUG DISCOVERY TODAY (2017)
Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation
Dean P. Staus et al.
NATURE (2016)
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy
Marie Godar et al.
SCIENTIFIC REPORTS (2016)
Nanobody-based cancer therapy of solid tumors
Marta Kijanka et al.
NANOMEDICINE (2015)
Application of BRET to monitor ligand binding to GPCRs
Leigh A. Stoddart et al.
NATURE METHODS (2015)
Probing the pharmacology of G protein-coupled receptors with fluorescent ligands
Leigh A. Stoddart et al.
NEUROPHARMACOLOGY (2015)
Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor
John S. Burg et al.
SCIENCE (2015)
Nanobodies: site-specific labeling for super-resolution imaging, rapid epitope-mapping and native protein complex isolation
Tino Pleiner et al.
ELIFE (2015)
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands
David C. Swinney et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
A robust pipeline for rapid production of versatile nanobody repertoires
Peter C. Fridy et al.
NATURE METHODS (2014)
Allosteric and biased G protein-coupled receptor signaling regulation: potentials for new therapeutics
Etienne Khoury et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes
A. O. Watts et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo
David Maussang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
Karl R. Schmitz et al.
STRUCTURE (2013)
Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
Mary P. Hall et al.
ACS CHEMICAL BIOLOGY (2012)
A simple, versatile method for GFP-based super-resolution microscopy via nanobodies
Jonas Ries et al.
NATURE METHODS (2012)
Preparation of unnatural N-to-N and C-to-C protein fusions
Martin D. Witte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae
A. Gorlani et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jahnichen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis
David Maussang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor - Transfer of binding site to the CXCR3 receptor
MM Rosenkilde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
AW Burgess et al.
MOLECULAR CELL (2003)
Share Paper
